Emergence of Ebola Virus Escape Variants in Infected Nonhuman Primates Treated with the MB-003 Antibody Cocktail.

[1]  Stephan Günther,et al.  Emergence of Zaire Ebola virus disease in Guinea. , 2014, The New England journal of medicine.

[2]  Michael McCarthy,et al.  US signs contract with ZMapp maker to accelerate development of the Ebola drug , 2014, BMJ : British Medical Journal.

[3]  J. Strong,et al.  Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp™ , 2014, Nature.

[4]  X. Qiu,et al.  Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb , 2013, Scientific Reports.

[5]  Stuart T. Nichol,et al.  Molecular Evolution of Viruses of the Family Filoviridae Based on 97 Whole-Genome Sequences , 2012, Journal of Virology.

[6]  Jens H. Kuhn,et al.  Ebola Virus Genome Plasticity as a Marker of Its Passaging History: A Comparison of In Vitro Passaging to Non-Human Primate Infection , 2012, PloS one.

[7]  P. Iversen,et al.  Discovery and Early Development of AVI-7537 and AVI-7288 for the Treatment of Ebola Virus and Marburg Virus Infections , 2012, Viruses.

[8]  Lisa Hensley,et al.  Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques , 2012, Proceedings of the National Academy of Sciences.

[9]  Glenn Tesler,et al.  Mapping single molecule sequencing reads using basic local alignment with successive refinement (BLASR): application and theory , 2012, BMC Bioinformatics.

[10]  Mauricio O. Carneiro,et al.  Pacific biosciences sequencing technology for genotyping and variation discovery in human data , 2012, BMC Genomics.

[11]  X. Qiu,et al.  Successful Treatment of Ebola Virus–Infected Cynomolgus Macaques with Monoclonal Antibodies , 2012, Science Translational Medicine.

[12]  Virgil L. Woods,et al.  Structural Basis for Differential Neutralization of Ebolaviruses , 2012, Viruses.

[13]  X. Qiu,et al.  Ebola GP-Specific Monoclonal Antibodies Protect Mice and Guinea Pigs from Lethal Ebola Virus Infection , 2012, PLoS neglected tropical diseases.

[14]  Yoshihiro Kawaoka,et al.  Structure of an Antibody in Complex with Its Mucin Domain Linear Epitope That Is Protective against Ebola Virus , 2011, Journal of Virology.

[15]  X. Qiu,et al.  Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies. , 2011, Clinical immunology.

[16]  V. Volchkov,et al.  Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs. , 2011, The Journal of infectious diseases.

[17]  Yoshihiro Kawaoka,et al.  A Shared Structural Solution for Neutralizing Ebolaviruses , 2011, Nature Structural &Molecular Biology.

[18]  A. Teacher,et al.  HapStar: automated haplotype network layout and visualization , 2011, Molecular ecology resources.

[19]  P. Iversen,et al.  Advanced antisense therapies for postexposure protection against lethal filovirus infections , 2010, Nature Medicine.

[20]  Joshua C. Johnson,et al.  Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study , 2010, The Lancet.

[21]  L. Excoffier,et al.  Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows , 2010, Molecular ecology resources.

[22]  P. Rollin.  Filoviruses: A Compendium of 40 Years of Epidemiological, Clinical, and Laboratory Studies , 2008, Emerging Infectious Diseases.

[23]  E. Saphire,et al.  Neutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it. , 2009, Current opinion in structural biology.

[24]  Heinz Feldmann,et al.  Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus , 2009, Journal of Virology.

[25]  Steven J M Jones,et al.  Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses. , 2008, Vaccine.

[26]  D. Burton,et al.  Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor , 2008, Nature.

[27]  L. Fernando,et al.  Effective Post-Exposure Treatment of Ebola Infection , 2007, PLoS pathogens.

[28]  D. A. Stein,et al.  Gene-Specific Countermeasures against Ebola Virus Based on Antisense Phosphorodiamidate Morpholino Oligomers , 2006, PLoS pathogens.

[29]  J. Wilson,et al.  Epitopes involved in antibody-mediated protection from Ebola virus. , 2000, Science.

[30]  D R Burton,et al.  Recombinant human monoclonal antibodies to Ebola virus. , 1999, The Journal of infectious diseases.

[31]  A. Sanchez,et al.  A system for functional analysis of Ebola virus glycoprotein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[32]  T. Gojobori,et al.  The origin and evolution of Ebola and Marburg viruses. , 1997, Molecular biology and evolution.

[33]  Kiyoshi Asai,et al.  PBSIM: PacBio reads simulator - toward accurate genome assembly , 2013, Bioinform..